SIRT1 and metabolic syndrome: CR delays development of insulin resistance, glucose intolerance, and dyslipidemia in the adipose tissue of normal mice, whereas lack of functional SIRT1 increases the incidence of those outcomes [513], indicating a role for SIRT1 against development of MetS-related symptoms.